Based on the laboratory findings of mild hyperglycemia, macrocytosis with low MCH and MCHC, elevated RDW, thrombocytosis, neutrophilia with increased immature granulocytes, elevated basophils, hyperkalemia, elevated BUN, and hypoalbuminemia, what is the likely diagnosis and recommended next steps in management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Laboratory Findings Suggest Inflammatory/Reactive Process with Possible Underlying Chronic Disease

These laboratory abnormalities most likely represent a reactive inflammatory or infectious process, potentially with underlying chronic disease or nutritional deficiency, rather than a primary hematologic malignancy. The combination of neutrophilia with immature granulocytes (left shift), thrombocytosis, elevated inflammatory markers (high RDW), and metabolic derangements points toward an acute-on-chronic inflammatory state.

Key Diagnostic Considerations

Hematologic Pattern Analysis

The macrocytosis (MCV 95.5) with paradoxically low MCH (25.7) and MCHC (26.8) is unusual and suggests a mixed picture. This combination can occur when:

  • Iron deficiency coexists with B12/folate deficiency 1
  • Chronic disease with nutritional deficiencies 1
  • The high RDW (17.1) supports this mixed deficiency state, as RDW is a key indicator of iron deficiency even when MCV appears normal or elevated 1

Inflammatory/Infectious Picture

The neutrophilia (70.8%) with elevated immature granulocytes (0.8%) and absolute neutrophil count (6.1) indicates an active left shift, suggesting:

  • Acute bacterial infection
  • Inflammatory process
  • Tissue necrosis or stress response

The thrombocytosis (495) combined with neutrophilia strongly suggests reactive thrombocytosis rather than a myeloproliferative disorder 2. Reactive causes include infection, inflammation, iron deficiency, and tissue damage.

The basophilia (2.3%) is mildly elevated but not at levels typically seen in chronic myeloid leukemia (which would also require BCR-ABL testing) 3.

Metabolic Derangements

  • Hyperglycemia (104): Mild elevation suggesting prediabetes or stress hyperglycemia 4
  • Elevated BUN (26) with hyperkalemia (5.2): Suggests prerenal azotemia, dehydration, or early renal dysfunction 5
  • Hypoalbuminemia (3.4): Indicates chronic inflammation, malnutrition, or protein loss 1

Recommended Diagnostic Workup

Immediate Priority Tests

Based on ECCO guidelines for anemia workup 1:

  1. Serum ferritin and transferrin saturation (TSAT) - Essential to distinguish iron deficiency from anemia of chronic disease
  2. CRP or ESR - Quantify inflammatory burden
  3. Reticulocyte count - Assess bone marrow response
  4. Vitamin B12 and folate levels - The macrocytosis with high RDW suggests possible deficiency 1
  5. Peripheral blood smear review - Look for:
    • Macro-ovalocytes and hypersegmented neutrophils (megaloblastic anemia) 6
    • Toxic granulation in neutrophils (infection)
    • Red cell morphology patterns

Secondary Evaluation

  1. Comprehensive metabolic panel - Assess renal function, liver function, and electrolytes more thoroughly
  2. Hemoglobin A1c - Evaluate chronic glycemic control 4
  3. Thyroid function tests - Hypothyroidism can cause macrocytosis 6
  4. Lactate dehydrogenase (LDH) and haptoglobin - If hemolysis suspected 1

Rule Out Serious Pathology

  1. If ferritin >100 μg/L with inflammation: Consider bone marrow evaluation if diagnosis remains unclear after initial workup 1
  2. Chest X-ray and cultures - Given neutrophilia with left shift, evaluate for occult infection 5
  3. Stool studies - If gastrointestinal symptoms present (iron loss, malabsorption)

Clinical Pitfalls to Avoid

Do not assume macrocytosis alone indicates B12/folate deficiency - The low MCH and MCHC with high RDW suggest coexisting iron deficiency 1. In inflammatory bowel disease contexts, ferritin <30 μg/L indicates iron deficiency without inflammation, but up to 100 μg/L may still represent iron deficiency in the presence of inflammation 1.

Do not overlook the lymphopenia (17.6%) - Combined with neutrophilia, this suggests an acute stress response or possible viral infection with secondary bacterial process.

The mild hyperglycemia warrants follow-up but is not the primary concern given the inflammatory picture. However, hyperglycemia can alter red blood cell parameters including increasing MCHC and affecting RDW 7, 8.

Most Likely Diagnosis

This pattern most strongly suggests:

  1. Acute infection or inflammatory process (neutrophilia, left shift, thrombocytosis)
  2. With underlying mixed nutritional deficiency (iron + possible B12/folate deficiency based on RDW and MCV pattern)
  3. Possible chronic disease component (hypoalbuminemia, prerenal azotemia)

The elevated immature granulocytes (0.07) is particularly important - this left shift indicates active bone marrow response to infection or inflammation, not a primary bone marrow disorder 3.

Management Algorithm

  1. Obtain ferritin, TSAT, CRP, reticulocyte count, B12, and folate immediately
  2. Review peripheral smear for megaloblastic changes and toxic granulation
  3. Evaluate for source of infection/inflammation (physical exam, imaging as indicated)
  4. Address dehydration/prerenal state (BUN elevation with hyperkalemia)
  5. If ferritin <30 μg/L or <100 μg/L with inflammation: Initiate iron supplementation 1
  6. If B12 <200 pg/mL or folate deficient: Initiate appropriate replacement 1
  7. Hematology referral if: Diagnosis unclear after extended workup, or if bone marrow evaluation needed 1

Recheck complete blood count in 2-4 weeks after addressing infection/inflammation and nutritional deficiencies to assess response and ensure no underlying primary hematologic disorder 5.

Related Questions

In a patient with a known history of fatty liver disease and celiac disease who presents with macrocytosis (mean corpuscular volume 108 fL), what is the most likely diagnosis?
Can increased alcohol intake cause an elevated Mean Corpuscular Volume (MCV) and how long would it take to normalize after a patient stops drinking?
In a 48-year-old patient with an MCV of 100 fL (macrocytosis), hemoglobin of 13.9 g/dL, and serum chloride of 109 mmol/L, what is the appropriate next step in evaluation and management?
What is the likely cause and recommended evaluation for a 63‑year‑old woman with macrocytosis (mean corpuscular volume 100 fL, mean corpuscular hemoglobin 33 pg, red‑cell distribution width 46.1 %)?
Can a person have baseline mild macrocytosis (Mean Corpuscular Volume (MCV) elevation) as a normal variant?
When can pharmacologic heparin prophylaxis be started after surgery?
What are the recommended dosing guidelines for ampicillin‑sulbactam (including the sulbactam component) in adult patients with complicated intra‑abdominal infections, complicated skin‑and‑soft‑tissue infections, or hospital‑acquired/ventilator‑associated pneumonia, and how should the dose be adjusted for renal impairment?
What is the recommended dosing and therapeutic approach for sulbactam in treating carbapenem‑resistant Acinetobacter baumannii infections?
What is the most appropriate initial test for evaluating a suspected invasive fungal infection?
What are the benefits of carbohydrate intake for children?
When should pharmacologic venous thromboembolism prophylaxis with heparin be initiated after neurosurgery?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.